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Abstract
Background: Mutations in the coding region of angiogenin (ANG) gene have been found in patients suffering from
Amyotrophic Lateral Sclerosis (ALS). Neurodegeneration results from the loss of angiogenic ability of ANG (protein coded by
ANG). In this work, we performed extensive molecular dynamics (MD) simulations of wild-type ANG and disease associated
ANG variants to elucidate the mechanism behind the loss of ribonucleolytic activity and nuclear translocation activity,
functions needed for angiogenesis.
Methodology/Principal Findings: MD simulations were carried out to study the structural and dynamic differences in the
catalytic site and nuclear localization signal residues between WT-ANG (Wild-type ANG) and six mutants. Variants K17I,
S28N, P112L and V113I have confirmed association with ALS, while T195C and A238G single nucleotide polymorphisms
(SNPs) encoding L35P and K60E mutants respectively, have not been associated with ALS. Our results show that loss of
ribonucleolytic activity in K17I is caused by conformational switching of the catalytic residue His114 by 99u. The loss of
nuclear translocation activity of S28N and P112L is caused by changes in the folding of the residues
31RRR
33 that result in
the reduction in solvent accessible surface area (SASA). Consequently, we predict that V113I will exhibit loss of angiogenic
properties by loss of nuclear translocation activity and L35P by loss of both ribonucleolytic activity and nuclear translocation
activity. No functional loss was inferred for K60E. The MD simulation results were supported by hydrogen bond interaction
analyses and molecular docking studies.
Conclusions/Significance: Conformational switching of catalytic residue His114 seems to be the mechanism causing loss of
ribonucleolytic activity and reduction in SASA of nuclear localization signal residues
31RRR
33 results in loss of nuclear
translocation activity in ANG mutants. Therefore, we predict that L35P mutant, would exhibit loss of angiogenic functions,
and hence would correlate with ALS while K60E would not show any loss.
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Introduction
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegener-
ative disorder. It is caused by selective destruction of motor
neurons [1]. A combination of several factors including protein
aggregation, mitochondrial dysfunction, oxidative stress, defective
axonal transport, excitotoxicity and dysfunctional growth factor
signaling have been linked to the onset of ALS. In the later stages
of the disease, paralysis sets in and death ensues due to
respiratory failure. Approximately 10% of the cases are inherited
in an autosomal dominant manner while 90% are sporadic.
Among the catalogued ALS-like motor neuron diseases, muta-
tions in SOD1 (ALS1), FUS/TLS (ALS6), VAPB (ALS8), ANG
(ALS9), TARDBP (ALS10), FIG4 (ALS11) and a hexanucleotide-
repeat expansion (GGGGCC) in the C9ORF72 cause adult onset
neurodegenerative disorder [2–4]. Deletion of the hypoxia-
response element in the vascular endothelial growth factor
(VEGF) promoter also caused adult onset motor neuron
degeneration similar to ALS in mice [5]. However, since
mutations in VEGF have not been found in ALS patients, VEGF
polymorphisms may be considered as a risk factor in some
populations [6]. Among the ALS types that portray the
characteristic adult onset neurodegenerative disorders, about
one-fifth of the familial cases are attributed to missense mutations
in the gene that encodes SOD1. Mutations in SOD1 gene cause
ALS through a toxic gain of function and not due to an
impairment of its antioxidant function [7] and hence SOD1
mimetics may not lead to an effective therapy. This and the fact
that most reported cases of ALS are sporadic, underscores the
importance of studying other gene mutations in detail.
Among other genes, heterozygous missense mutations in ANG
have been associated with ALS [2]. ANG, a 123 amino acid single
chain polypeptide (14.1 kDa), is strongly expressed in both
endothelial cells and motor neurons in prenatal and adult spinal
cord of humans. It influences the physiology and health of motor
neurons by stimulating angiogenesis, neurite outgrowth and path-
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maintains normal vasculature and thereby protects motor neurons
from various stress conditions. Wu et al. [8] have shown using
angiogenesis, ribonucleolysis, and nuclear translocation assays that
ANG mutations identified in ALS patients are associated with
functional loss of angiogenic activity. Baker et al. [10] and Cruts
et al. [11] have also observed null mutations in another angiogenic
protein, progranulin (PGRN), in frontotemporal dementia (FTD)
patients. Mutations of PGRN gene were also reported in ALS
patients [12]. Since compromised angiogenic activity appears to
play a pivotal role in ALS progression, a study of the effect of
selected mutations on the function of ANG may help in defining a
better therapy.
ANG executes its essential functions via three functional sites
(Figure 1). The first functional site, comprising the catalytic triad
His13, Lys40 and His114, is responsible for ribonucleolytic
activity. The second functional site consists of the nuclear
localization signal
29IMRRRGL
35, which resides on the surface
of ANG and facilitates its translocation into nucleolus. In
endothelial cells and motor neurons, ANG undergoes nuclear
translocation, binds to the promoter region of ribosomal DNA
and helps in ribosome biogenesis, protein translation and cell
proliferation by stimulating rRNA transcription. The third
functional site is the receptor-binding site
60NKNGNPHREN
68,
which is responsible for the binding of ANG to the endothelial
cells, motor neurons and induces second messenger responses.
Recent experimental studies have shown that mutations in ANG
result in the loss of either ribonucleolytic activity, nuclear
translocation activity or both and any single loss of either of
these functions leads to the complete loss of angiogenic function
which in turn causes ALS [8]. More than 15 ANG mutations have
been associated with ALS of which 10 have been studied in detail
[8,9,13,14–20]. However, the molecular mechanism behind the
functional loss of ANG due to these mutations is not completely
understood.
In order to explain how these mutations resulted in the loss of
either ribonucleolytic activity or nuclear translocation activity,
or both, we have conducted a series of molecular dynamics
(MD) simulations including all structurally different mutant
f o r m st h a th a v ec o m p l e t er i b o n u c leolytic and nuclear translo-
cation activity information, except those near the catalytic site,
so that our MD simulation results can be validated [8]: (i) K17I
which results in the loss of ribonucleolytic activity, (ii) S28N
which has only 9% of ribonucleolytic activity and no nuclear
translocation activity, and (iii) P112L which results in partial
ribonucleolytic activity and complete loss of nuclear transloca-
tion activity. We also studied the V113I variant which is
prevalent among Italian patients [16]. In addition, our study
included two missense SNPs, T195C and A238G at the gene
level encoding L35P and K60E mutants respectively, not yet
clinically correlated with ALS [21]. We performed 50 ns
duration MD simulations of the WT-ANG, disease associated
K17I, S28N, P112L and V113I variants and L35P and K60E
mutants with AMBER 10 software suite. The sites of these
mutations are shown in Figure 2.
This is the first study using MD simulations that presents an
explanation for the loss of functions observed in ANG mutations.
Our MD simulations demonstrate that a possible molecular
mechanism may involve a change in conformation of the catalytic
triad residue His114 resulting in the loss of ribonucleolytic activity.
Simulation results confirm structural instability of ANG variants as
reported in experimental studies. Further, we predict that L35P
mutant may be responsible for causing ALS by loss of
ribonucleolytic activity as well as nuclear translocation activity
while K60E may be passive.
Methods
System setup
The crystal structure of human angiogenin (PDB: 1B1I) was
used as the starting point [22]. The hetero atoms (crystallo-
graphic waters and cofactor, CIT) were removed from the
structure before simulation. WT-ANG has three disulfide bonds
Cys
26–Cys
81,C y s
39–Cys
91 and Cys
57–Cys
107 which were
processed according to AMBER protocols. To model the
starting structures of mutants K17I, S28N, P112L, L35P,
Figure 1. Cartoon representation of X-ray structure for Human Angiogenin (PDB code: 1B1I). Cartoon representation of the structure of
Human Angiogenin (PDB entry 1B1I) showing its functional sites; catalytic triad residues are represented as stick models, nuclear localization signal is
represented in magenta color and receptor binding site is represented in orange color. Figure produced using PyMOL [53].
doi:10.1371/journal.pone.0032479.g001
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mutated the corresponding residues in silico by replacing the
target residues with the desired amino acids, keeping the
secondary structures intact. All hydrogen atoms were added
using the Xleap tool of AMBER 10 [23]. The system was
solvated in an octahedral box of TIP3P water with ,10 A ˚
between the protein surface and the box boundary [24]. The
free protein was neutralized by adding Cl
2 counter ions for
individual models. The SANDER module of AMBER 10
package was used for all the MD simulations.
Figure 3. RMSD and RMSF profile for WT-ANG and mutants. (A) Control plots representing the stability of the models during the molecular
dynamics run. The root mean square deviation (RMSD) of the backbone atoms from the equilibrated conformation (0 ns) is presented as a function of
time. The RMSD time profiles for WT-ANG, K17I, S28N, P112L, L35P, K60E and V113I are shown in black, red, dark green, blue, orange, pink, and light
green, respectively. (B) Root mean square fluctuation (RMSF) values of atomic positions computed for the backbone atoms are shown as a function of
residue number. The RMSF values for WT-ANG, K17I, S28N, P112L, L35P, K60E and V113I are shown in black, red, dark green, blue, orange, pink, and
light green, respectively.
doi:10.1371/journal.pone.0032479.g003
Figure 2. Ribbon representation of mutational sites in Human Angiogenin. Ribbon representation of structure of Human Angiogenin (PDB
entry 1B1I) with mutational sites; mutations are labeled and represented as stick models in orange color. Figure produced using PyMOL [53].
doi:10.1371/journal.pone.0032479.g002
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Simulations were initiated using the model of WT-ANG, K17I,
S28N, P112L, L35P, K60E and V113I mutants of ANG and each
simulation was performed for 50 ns in the isothermal isobaric
ensemble (NPT). All simulations were performed according to the
standard protocols, which consists of energy minimization,
followed by gradual heating of the system. Each system was
initially minimized employing 2500 steps of steepest descent
followed by 1000 steps conjugate gradient minimization. Topology
and parameter files for the protein were generated using ‘‘ff99SB’’
force field [25]. Each system was then gradually heated from 0 to
300 K in 200 ps followed by constant temperature equilibration at
300 K for 1000 ps. Following the equilibration phase, 50 ns MD
simulations were carried out with periodic boundary conditions in
the NPT ensemble, at a temperature of 300 K with Berendsen
temperature coupling and a constant pressure of 1 atm with
isotropic molecule-based scaling [26]. SHAKE algorithm was
applied to fix all covalent bonds containing hydrogen atoms [27].
A1 0A ˚ cutoff was applied to treat nonbonding interactions such as
short-range electrostatics and van der Waals interactions, while the
particle-mesh-Ewald (PME) method was used for long-range
electrostatic interactions [28]. The coordinates of the trajectory
was sampled every 1 ps for analysis of the energy stabilization and
the root mean square deviations (RMSD) of the protein. The
analyses of MD simulations were carried out by PTRAJ module of
AMBER 10. MD simulations were performed on a 320 processor
SUN Microsystems cluster at the Supercomputing Facility (http://
www.scfbio-iitd.res.in) of Indian Institute of Technology Delhi.
Molecular Docking
AutoDock 4.2 suite was used as molecular docking tool in
order to carry out the docking simulations [29,30]. Snapshots
Figure 4. Conformational switching of catalytic residue His114 in K17I and L35P mutants. Orientation of the catalytic triad residue His114
at a regular interval of 10 ns during the MD simulations of K17I and L35P mutants. In these figures, T=0 ns is the start of production phase post-
equilibration. Figure produced using PyMOL [53].
doi:10.1371/journal.pone.0032479.g004
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altered His114 conformations and these structures were used for
docking studies. The ligand molecule NCI-65828, which is an
inhibitor of ribonucleolytic activity of ANG, was retrieved from
NCBI-PubChem Compound database [PubChem: 5351857].
Docking logs were analyzed in the graphical user interface of
ADT 1.5.4 [31]. Water molecules and Cl
2 counter ions were
cleaned off from the protein structure before docking. H-atoms
were added to the target protein for correct ionization and
tautomeric states of amino acids and the non-polar hydrogens
were then merged. Kollman united atom charges and solvation
parameters were assigned to the protein. Gasteiger charges were
assigned to the ligand. The structures so obtained were converted
to PDBQT format in ADT. The Lamarckian Genetic Algorithm
was used with a population size of 150 dockings and 2.5 million
energy evaluations were used in the docking experiments. All
other parameters, such as crossover rate and mutation rate, were
run with default settings. The grid size for specifying the search
space was set at 80680680 centered on the macromolecule with
a default grid point spacing of 0.375 A ˚. Pre-calculated grid maps,
which store grids of interaction energy based on the interaction of
the ligand atom probes with receptor target, were obtained using
AutoGrid. The results were clustered into bins of similar
conformations based on root mean square deviation (RMSD)
and orientation.
The binding energies were also calculated using ParDOCK
which is an all atom energy based Monte Carlo docking protocol
[32–34]. Docking using ParDOCK requires a reference complex
(target protein bound to a reference ligand) and a candidate
molecule along with specific mention of the centre of mass of the
cavity on which the ligand is to be docked. The active sites were
predicted using Active Site Prediction server (http://www.scfbio-
iitd.res.in/dock/ActiveSite.jsp), which computes cavities in the
protein. The cavity in close proximity to His114 was used for
docking the compound NCI-65828.
Solvent accessible surface area
Solvent-accessible surface area (SASA) of nuclear localization
signal residues
31RRR
33 was calculated for the entire simulation
period using SurfVol, a Plug-in for Visual Molecular Dynamics
(VMD) software (version 1.8.7) [35] for measuring the surface area
of proteins (http://www.compbiochem.org/Software/SurfVol/
Home.html). The box used for the surface area calculation was
centered on residues of the nuclear localization signal. For the
seven cases studied in this work, SASA was calculated using a
probe radius of 1.4 A ˚.
Figure 6. Hydrogen bond interaction network for K17I variant. The hydrogen bond interactions between contiguous amino acid residues
based on a 3.2 A ˚ cut-off has been presented here. The path leading from the site of mutation Ile17 to catalytic residue His114 has been shown in blue
square boxes. Other hydrogen bond interactions are shown in grey circles. The bond length is given on the edge between the nodes of amino acid
residues. The path is mediating through Leu115 which plays a role in His114 conformational switching.
doi:10.1371/journal.pone.0032479.g006
Figure 5. Computed change in HA-CA-CB-CG dihedral angle of His114 for WT-ANG and mutants. The HA-CA-CB-CG dihedral angle
change of catalytic residue His114 computed as a function of time (A) WT-ANG (B) K17I (C) S28N (D) P112L (E) L35P (F) K60E and (G) V113I.
doi:10.1371/journal.pone.0032479.g005
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The objective of our simulation study was to determine the
underlying cause for the loss of ribonucleolytic activity and nuclear
translocation activity of ANG reported in ALS patients, and
predict the role of certain SNPs reported in ANG but not yet
clinically correlated in ALS patients. We observed the following
steps to achieve this goal. The WT-ANG was simulated first and
the results were compared with the crystal structure. This was
followed by simulations of known disease associated variants K17I,
S28N and P112L. Finally, simulations were performed for L35P,
K60E and V113I mutants. The results of MD simulations have
been supported with hydrogen-bond interaction analyses and
docking studies of an inhibitor to the active site. Solvent accessible
surface areas (SASA) were determined over the MD trajectories to
understand changes in nuclear translocation activity.
MD Simulations
The reliability of the system setup for performing the MD
simulation was first evaluated using WT-ANG crystal structure as
the basis because the crystal structures of the mutants were not
available. The simulated structure of WT-ANG, obtained by
averaging of all the frames in the 50 ns period, was superposed on
the crystal structure and the root mean square deviation (RMSD)
was found to be 0.30 A ˚. The root mean square fluctuation (RMSF)
values calculated from the B-factor for the crystal structure and
that obtained from the MD simulation were compared and found
to be in good agreement (see Figure S1). We also validated the
50 ns period by performing a simulation of WT-ANG in which
His114 was rotated a priori by 99
o. We observed that within 1 ns,
His114 of WT-ANG acquires its native conformation (see Figure
S2) and consequently 50 ns was used in all MD simulations. In
addition, we captured the structures of K17I, S28N and L35P
mutants when His114 changed its conformation by 99u. We then
computationally mutated each site of mutation back to the WT-
ANG sequence and carried out a fresh set of MD simulations with
these altered structures. It was observed that these structures
returned to their WT-ANG conformation within 1 ns and
remained stable thereafter. These results validated the MD model,
which was then used for subsequent simulation experiments and
analyses.
MD simulations of all the mutants were performed for 50 ns
to determine if there was any structural difference with WT-
ANG that deserved attention. No major difference in the side
chain orientations was observed. The RMSD and RMSF values
obtained from the MD simulations of WT-ANG compared to
K17I, S28N, P112L and V113I variants, and L35P and K60E
mutants have been presented (Figure 3). It was observed that the
RMSD of K17I was initially higher compared to the others.
However, after 20 ns, the RMSDs in all cases are nearly similar
(Figure 3A). The RMSF profiles were determined for the
mutants and it was observed that in each case the highest
fluctuation occurs at the point of mutation (Figure 3B). It was
also observed that K17I mutation affects neighboring residues
resulting in a higher RMSF up to residue 40. Further, the
RMSF values for P112L and V113I were lower between
residues 40 and 80 indicating a loss of flexibility caused by
these mutations.
Figure 7. Hydrogen bond interaction network for S28N variant. The hydrogen bond interactions between contiguous amino acid residues
based on a 3.2 A ˚ cut-off has been presented here. The path leading from the site of mutation Asn28 to catalytic residue His114 has been shown in
blue square boxes. Other hydrogen bond interactions are shown in grey circles. The bond length is given on the edge between the nodes of amino
acid residues. The path is mediating through Leu115 which plays a role in His114 conformational switching.
doi:10.1371/journal.pone.0032479.g007
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Loss of Ribonucleolytic Activity. The catalytic triad of
ANG consisting of Lys40, His13 and His114, confers
ribonucleolytic activity on the protein. The catalytic triad was
visualized using VMD [35] and it was observed that the
orientation of His114 in the K17I variant changed significantly
compared to WT-ANG. Snapshots of the catalytic triad at 10 ns
intervals for K17I and L35P are given in Figure 4. For other
mutants, the snapshots of catalytic triad at 10 ns intervals are
given in Figures S3 and S4. The HA-CA-CB-CG dihedral angle
of His114 was measured throughout the course of the simulation.
It was observed that the dihedral angle changed from the mean
280u position of the WT-ANG and assumed a new dihedral
orientation of 2179u for K17I during most of the simulation
period (Figures 5A and 5B). The L35P mutant also showed a
similar change in conformation to 2179u for the dihedral angle
but for shorter durations (Figure 5E). The variants S28N and
P112L showed changes in the dihedral angle after 20 ns
(Figures 5C and 5D). The longer duration of dihedral change
of His114 for S28N correlates with the reported observation that
it retains 9% of ribonucleolytic activity and the shorter duration
for P112L correlates with partial loss of activity [8]. The
remaining mutants, K60E and V113I, did not exhibit this shift in
dihedral and had profiles similar to WT-ANG (Figures 5F and
5G).
Hydrogen Bonding Interactions. The observation that only
the His114 of the catalytic triad exhibited a significant change in
the dihedral angle was further examined. Hydrogen-bond
interactions from the site of mutation to His114 were analyzed
to understand how a single mutation could cause the observed
conformational switch.
We observed that amino acids linked by hydrogen bonds were
different for the mutants examined and hence used UCSF
CHIMERA package [36] to identify the amino acid residues
linked by hydrogen bonds (cut-off #3.2 A ˚). The hydrogen bond
interaction network was visualized using Cytoscape [37] and all
paths obtained were confirmed by adjacency matrix analysis using
a MATLAB program. The paths starting from the site of mutation
to His114 were identified for K17I, S28N, L35P and K60E
mutants and presented (Figures 6, 7, 8, 9) but not for V113I and
P112L variants because of their proximity to His114. In each case,
we determined the shortest path leading from the site of mutation
Figure 8. Hydrogen bond interaction network for L35P mutant. The hydrogen bond interactions between contiguous amino acid residues
based on a 3.2 A ˚ cut-off has been presented here. The paths leading from the site of mutation Pro35 to catalytic residue His114 have been shown in
blue square boxes. Other hydrogen bond interactions are shown in grey circles. The bond length is given on the edge between the nodes of amino
acid residues. One of the path is mediating through Leu115 which plays a role in His114 conformational switching and the other path is mediating
through Thr44 similar to that of WT-ANG.
doi:10.1371/journal.pone.0032479.g008
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His13-Leu115-Gln117-Asp116-His114-Ala106-Val113 as repre-
sented (Figures 6, 10) and the corresponding equivalent path in
WT-ANG was Lys17-Asp15-Ile46-His13-Thr44-Gln117-Asp116-
His114-Ala106-Val113 (Figure 11). Two amino acids following
His114 have also been considered because these participate in the
conformational switching of His114. We also captured snapshots
at the point of conformational switching of His114 for various time
instances in the case of mutants exhibiting loss of ribonucleolytic
activity and found that the shortest path is always conserved.
Next, the hydrogen-bond occupancy for each adjacent pair of
amino acids appearing in the path was determined for 50 ns
(Table 1). We observed that hydrogen bonding between His114-
Ala106 and Ala106-Val113 increases significantly in K17I
mutant. Hydrogen bond occupancy for His114-Ala106 and
Ala106-Val113 was 50.88% and 38.48% higher, compared with
WT-ANG. In L35P, two possible paths were identified, the first
mediated through Leu115 and the second through Thr44
(Figures 8, 12). A comparison of the Thr44 mediated path
between L35P and WT-ANG showed 38.48% and 20.05%
higher occupancies for His114-Ala106 and Ala106-Val113,
which correlated with the shorter duration of dihedral angle
shift.
We also examined the total hydrogen bond occupancy for the
shortest path. The sum of hydrogen bond occupancy of all the
pairs was 280.39 for K17I compared to 187.99 for WT-ANG
(Table 1). The highest sum for hydrogen bond in L35P was
232.57. These results show that the higher hydrogen bond
occupancy for His114-Ala106 and Ala106-Val113 is instrumental
in shifting the dihedral angle from 280u to 2179u. The hydrogen
bond interaction networks for S28N and K60E mutants were also
created. It was observed that S28N possesses a shortest path
mediated through Leu115, while for K60E, it is mediated through
Thr44 (Figures 7, 9; Figure S5).
Structural study reveals that Leu115 in ANG plays a similar
functional role as Phe120 does in RNase A. The presence of
Leu115 in ANG removes potential interactions with the
pyrimidine ring and contributes to weaker ribonucleolytic activity
[22]. Our results show that hydrogen bond interaction paths
mediated through Leu115 are associated with conformational
switching of His114 in mutants exhibiting loss of ribonucleolytic
activity. It was also observed that the change in the dihedral angle
Figure 10. Residues interacting through hydrogen bonds from the site of mutation to His114 in K17I variant. Amino acid residues of
K17I variant through which hydrogen bonds exert influence from the site of mutation on the catalytic site His114. The ribbon representation shows
the shortest path traced by the contiguous amino acid sequence Ile17-Asp15-Ile46-His13-Leu115-Gln117-Asp116-His114-Ala106-Val113 and the
hydrogen bond interactions. Residues have been shown in stick model in marine blue color. Catalytic triad residues have been shown as stick model
and represented in green color. Hydrogen bonds between residues have been shown in red dashed-lines. Figure produced using PyMOL [53].
doi:10.1371/journal.pone.0032479.g010
Figure 9. Hydrogen bond interaction network for K60E mutant. The hydrogen bond interactions between contiguous amino acid residues
based on a 3.2 A ˚ cut-off has been presented here. The path leading from the site of mutation Glu60 to catalytic residue His114 has been shown in
blue square boxes. Other hydrogen bond interactions are shown in grey circles. The bond length is given on the edge between the nodes of amino
acid residues. The path is mediating through Thr44 similar to that of WT-ANG and there is no conformational switching of His114.
doi:10.1371/journal.pone.0032479.g009
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realignment of Gln117 stabilizes the altered dihedral position of
His114. The new orientation of Gln117 in the proximity of the
catalytic triad obstructs the pyrimidine-binding site. The
hydrogen bond between Thr44 and Thr80 has also been
implicated in the loss of ribonucleolytic activity [22]. Crystal
structure of ANG shows the existence of a hydrogen bond
between Thr44 and Thr80, and Asp116 and Ser118 [22]. The
weak ribonucleolytic activity compared to RNase A has been
attributed to the presence of these hydrogen bonds. Since these
hydrogen bonds may be altered in the mutants, we determined
the percentage hydrogen bonding occupancy between Thr44 and
Thr80 as well as Asp116 and Ser118 from MD trajectories.
Percentage hydrogen bonding occupancy of WT-ANG and
mutants has been presented (Table 2). We observed that the
hydrogen bonding occupancy in case of K17I, S28N and L35P
mutants were about 30% higher compared to WT-ANG, P112L,
K60E and V113I mutants for Thr44-Thr80. For the Asp116-
Ser118 hydrogen bond, the occupancy was about 20% higher for
the K17I, S28N variants and L35P mutant.
Docking Analyses. As revealed from simulation, the dihedral
angle of His114 in case of K17I variant and L35P mutant changes
significantly and may result in the loss of ribonucleolytic activity.
To confirm this, we carried out molecular docking simulations for
WT-ANG and K17I, S28N, P112L, L35P, K60E and V113I
mutants with an inhibitor of ribonucleolytic activity of angiogenin,
NCI-65828. Snapshots of the native and altered His114
conformation were extracted from MD trajectories over 50 ns.
These structures were used to carry out docking simulations and
explain the loss of ribonucleolytic activity [38]. A strong
interaction with WT-ANG and the inhibitor was observed as
expected in the native conformation possessing ribonucleolytic
activity (see Figure S6). Similarly, docking between the inhibitor
and K17I, S28N, P112L, V113I variants and L35P, K60E
mutants were performed using AutoDock [29,30] and ParDOCK
[32–34] and the binding energies for each case were determined
and presented (Table 3). It was observed that the binding energy in
those cases where the dihedral angle of the His114 changes
significantly was lower compared to the WT-ANG conformation.
In addition to this, the hydrogen-bond interactions for each
docked conformation were examined. It was observed that the
hydrogen bond between the azo-group of NCI-65828 and His114
HD1 exists only for WT-ANG catalytic triad conformation. In the
case of K17I and L35P mutants, where there is a conformational
switching of the His114, the hydrogen bond ceases to exist when
the dihedral angle of His114 shifts by 99u (Figure 13). Binding
Figure 11. Hydrogen bond interaction network for WT-ANG. The hydrogen bond interactions between contiguous amino acid residues
based on a 3.2 A ˚ cut-off has been presented here. All hydrogen bond interaction paths up to catalytic residue His114 have been compared with the
hydrogen bond interaction paths of other mutants. These hydrogen bond interactions are shown in blue square boxes. Other hydrogen bond
interactions are shown in grey circles. The starting residues through which these paths led to His114 are shown in pink square boxes. The bond
length is given on the edge between the nodes of amino acid residues. All the hydrogen bond interaction paths are mediating through Thr44 and
there is no conformational switching of His114.
doi:10.1371/journal.pone.0032479.g011
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altered conformations is shown as surface model (see Figure S7).
Loss of Nuclear Translocation Activity. Wu et al. [8]
reported S28N and P112L mutations in ANG obtained from
North American ALS cohort. Through their functional assay
experiments, they established that these mutations in ANG
resulted in loss of nuclear translocation activity. Since nuclear
localization signal of ANG is exposed on the protein surface and
largely accessible to solvent, the effect of change in the solvent
accessible surface area (SASA) on nuclear translocation activity
was investigated. SASA of the nuclear localization signal residues
(
31RRR
33) was calculated for each mutant and compared with
WT-ANG. SASA was determined for 50 ns for Arg31, Arg32
and Arg33, the three successive Arginine residues known to play
a pivotal role in nuclear translocation activity (Figure 14). The
average SASA over successive 10 ns time intervals was
calculated for each mutant and WT-ANG. It was observed
that SASA values for S28N, P112L and L35P mutants stabilized
after 10 ns, while the others stabilized after 30 ns (see Figure S8).
Considering the last 10 ns duration, we noticed that the variants
S28N and P112L have SASA below 15 A ˚ 2 compared to WT-
ANG and K17I, which possessed SASA above 385 A ˚ 2
(Figure 14). This difference of more than 350 A ˚ 2 correlated
with experimentally determined loss of nuclear translocation
activity [8]. We also observed that the SASA for L35P and
V113I mutants were even lower. However, K60E had a SASA of
388 A ˚ 2. In addition, the snapshots of nuclear localization signal
residues obtained at 50 ns revealed that
31RRR
33 was loosely
packed for WT-ANG and mutants exhibiting no loss of nuclear
translocation activity, while it was tightly packed for mutants
exhibiting loss of nuclear translocation activity (Figure 15). The
volume of the smallest sphere in which the residues
31RRR
33 can
fit was computed for the entire period of simulation and is shown
(see Figure S9). It was observed that average sphere volume for
WT-ANG, K17I and K60E, which exhibited no loss of nuclear
translocation activity, was greater than 2502 A ˚ 3. The mutations
L35P, S28N, P112L and V113I, which exhibited loss of nuclear
translocation activity had average sphere volumes less than
804 A ˚ 3 (Table 4).
F-SNP database prediction for L35P and K60E
mutants. We have verified using F-SNP database [39]
(http://compbio.cs.queensu.ca/F-SNP/) that T195C SNP
encoding L35P mutant would have a detrimental effect on ANG
and is likely to cause ALS. F-SNP computes a functional
significance (FS) score [40], using a tool reliability (TR) score
based on Bayes’ rule and information obtained from 16
bioinformatics tools and databases. For L35P mutant, the FS
score obtained was 0.764 and classified as deleterious. Similarly,
the FS score obtained for A238G SNP encoding K60E mutant was
0.533 and classified as benign. This further supports our result that
T195C SNP encoding L35P mutant would be correlated with
ALS.
Table 1. Percentage hydrogen bonding occupancy of adjacent pairs of amino acids for K17I, S28N, L35P and K60E in increasing
order of ribonucleolytic activity.
H-bond Path WT-ANG K17I H-bond Path WT-ANG L35P
Donor-acceptor % % Donor-acceptor % % %
Lys17 (Ile17)-Asp15 10.22 0.55 Leu35 (Pro35)-Lys40 8.25 10.12 10.12
Asp15-Ile46 4.47 4.80 Lys40-Gln12 7.37 13.50 13.50
Ile46-His13 37.53 38.41 Gln12-His13 9.51 6.42 6.42
His13-Thr44 (Leu115) 21.74 18.61 His13-Thr44 (Leu115, Thr44) 21.74 17.28 16.59
Thr44 (Leu115)-Gln117 25.31 30.83 Thr44 (Leu115, Thr44)-Gln117 25.31 19.84 38.31
Gln117-Asp116 15.57 23.88 Gln117-Asp116 15.57 9.73 9.73
Asp116-His114 2.72 3.52 Asp116-His114 2.72 8.94 8.94
His114-Ala106 27.33 78.21 His114-Ala106 27.33 65.81 65.81
Ala106-Val113 43.10 81.58 Ala106-Val113 43.10 63.15 63.15
H-bond Path WT-ANG S28N H-bond Path WT-ANG K60E WT-ANG K60E
Donor-acceptor % % Donor-acceptor % % % %
Ser28 (Asn28)-Arg32 17.61 15.56 Lys60 (Glu60)-Lys73 3.55 1.38 *Phe45-Asn43 0.57 2.15
Arg32-Asp15 3.87 6.47 Lys73-Asn61 39.17 42.77 Asn43-Gln12 52.11 1.49
Asp15-Ile46 4.47 5.91 Asn61- Ser74 14.39 30.65 Gln12-His13 9.51 23.01
Ile46-His13 37.53 38.33 Ser74-Ser72 63.61 60.12 His13-Thr44 21.74 42.73
His13-Thr44 (Leu115) 21.74 22.50 Ser72-Asn102 2.29 3.30 Thr44-Gln117 23.51 44.17
Thr44 (Leu115)-Gln117 25.31 14.37 Asn102-Arg101 28.60 55.38 Gln117-Asp116 15.57 23.48
Gln117-Asp116 15.57 31.42 Arg101-Phe76 52.73 64.72 Asp116-His114 2.72 3.36
Asp116-His114 2.72 3.11 Phe76-Val78 1.49 2.93 His114-Ala106 27.33 32.27
His114-Ala106 27.33 70.68 Val78-Thr79 2.96 1.85 Ala106-Val113 43.10 61.57
Ala106-Val113 43.10 64.14 Thr79-Phe45* 62.73 83.37
Italic font amino acid residues in parenthesis: Mutated residues.
Normal font amino acid residues in parenthesis: Amino acids appearing in hydrogen bond interaction path of mutants.
*Continuation of hydrogen bond interaction path.
doi:10.1371/journal.pone.0032479.t001
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PLoS ONE | www.plosone.org 12 February 2012 | Volume 7 | Issue 2 | e32479Figure 12. Residues interacting through hydrogen bonds from the site of mutation to His114 in L35P mutant. Amino acid residues of
L35P mutant through which hydrogen bonds exert influence from the site of mutation on the catalytic site His114. There were two shortest paths
identified. The first mediated through Leu115 and the second mediated through Thr44. Residues have been shown as stick models in marine blue
color. Catalytic triad residues have been shown as stick model and represented in green color. Hydrogen bonds between residues have been shown
in red dashed-lines. (A) The ribbon representation shows the path traced by the contiguous amino acid sequence Pro35-Lys40-Gln12-His13-Leu115-
Gln117-Asp116-His114-Ala106-Val113 (B) The ribbon representation shows the path traced by the contiguous amino acid sequence Pro35-Lys40-
Gln12-His13-Thr44-Gln117-Asp116-His114-Ala106-Val113. Figure produced using PyMOL [53].
doi:10.1371/journal.pone.0032479.g012
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Through the results of this investigation, we have established
that the conformational switching of His114 of the catalytic triad
of ANG is responsible for the loss of ribonucleolytic activity. We
calculated the changes in the dihedral angle, performed hydrogen
bond interaction analyses and carried out docking simulations with
an inhibitor to ascertain this. We first established that our
observations were in line with the clinical and experimental
findings in the literature. We built our discussion around K17I
variant and L35P mutant. Using the results of K17I as a basis, we
predict that L35P may also exhibit loss of angiogenic activity and
its association with ALS.
Loss of Ribonucleolytic Activity
The loss of ribonucleolytic activity of ANG mutants was
examined by scanning through the snapshots of the catalytic triad
at various time instances during VMD visualization. We observed
that among the residues His13, Lys40 and His114, only His114
exhibited dramatic changes in conformation relative to the
positions of the other residues. Therefore, the HA-CA-CB-CG
dihedral angle of His114 was measured for the whole duration of
simulation for WT-ANG and all the mutants. Snapshots were
taken at 10 ns intervals and correlated with the change in the
dihedral angles compared to the native position in WT-ANG
(Figure 4, Figures S3 and S4). The observed loss in ribonucleolytic
activity varied from severe in K17I, S28N and L35P to mild in
P112L and insignificant in K60E and V113I, and this correlated
positively with the frequency with which the dihedral angle
changed from 280u to 2179u (Figures 4, 5; Figures S3 and S4).
Our observations find support in the work of Wu et al. [8], who
identified four mutations in the coding region of ANG from 298
ALS patients. They showed using functional assays that these
mutants exhibited a complete loss of angiogenic activity due to
either loss of ribonucleolytic activity, loss of nuclear translocation
activity or both. They reported that K17I variant had lost more
than 95% ribonucleolytic activity, whereas, S28N and P112L had
lost nuclear translocation activity, although, S28N had 9% and
P112L had partial ribonucleolytic activity. The importance of each
of the residues of the catalytic triad, His13, Lys40 and His114, had
been established by a series of site directed mutagenesis work
carried out by Shapiro’s group. They observed a significant
decrease in ribonucleolytic activity by replacing His13 or His114
by Ala [41] or Lys40 by Gln [42]. Since His114 is the more
important residue of the catalytic triad, the H114N mutant
exhibited a 3300 fold reduction in activity [41]. Our simulation
results also show that it is only the His114, which exhibits
conformational switching in mutants exhibiting loss of ribonu-
cleolytic activity. Subsequent crystal structure studies (2.0 A ˚)o f
two of these active sites of the catalytically inactive variants K40Q
and H13A, showed no significant changes outside the catalytic site.
Loss of angiogenicity was attributed to the disruption of the
catalytic triad [22]. Our RMSD and RMSF results also did not
show any major difference between the mutants and WT-ANG
(Figure 3). Consequently, the question arises as to how does a
mutation distal from the active site affects ribonucleolytic activity
because the resulting loss in ribonucleolytic activity is not intuitive
from the crystal structure.
To understand how this may happen, we first examined the
hydrogen bond interaction networks for K17I, S28N, L35P and
K60E mutants. We identified based on a 3.2 A ˚ cut-off, a shortest
path by which contiguous hydrogen bonds may exercise influence
from the site of mutation to His114 (Figures 6, 7, 8, 9). The
hydrogen bond occupancy of each adjacent amino acid pair
appearing in this path was computed. For all cases where
conformational switching of His114 was observed in the
simulations, there was a significant increase in hydrogen bond
occupancies between His114-Ala106 and Ala106-Val113. Further,
it was observed that the shortest path was conserved for mutants
exhibiting loss of ribonucleolytic activity during conformational
switching of His114; while other paths leading from the site of
mutation to His114 lost continuity during reorientation of His114.
del Sol et al. [43] have also identified conserved residues that occur
in shortest paths and play a vital role in long range interactions
Table 2. Percentage hydrogen bonding occupancy between
Thr44-Thr80 and Asp116-Ser118.
ANG H-bonding occupancy (%)
Thr44 — Thr80 Asp116 — Ser118
WT-ANG 51.38 62.18
K17I 96.87 95.31
S28N 82.51 74.27
P112L 53.66 69.24
L35P 84.59 89.36
K60E 49.92 61.76
V113I 50.36 63.15
doi:10.1371/journal.pone.0032479.t002
Table 3. Comparison of AutoDock and ParDOCK binding energy scores for NCI-65828 complexes with WT-ANG and ANG mutants.
AutoDock binding energy scores ParDOCK binding energy scores
ANG Native conformation Altered conformation Native conformation Altered conformation
WT-ANG* 28.74 kcal/mol 24.83 kcal/mol
K17I 27.72 kcal/mol 24.84 kcal/mol 23.33 kcal/mol 22.44 kcal/mol
S28N 26.28 kcal/mol 24.46 kcal/mol 23.87 kcal/mol 23.00 kcal/mol
P112L 27.66 kcal/mol 24.38 kcal/mol 23.49 kcal/mol 22.99 kcal/mol
L35P 27.04 kcal/mol 24.63 kcal/mol 23.57 kcal/mol 21.97 kcal/mol
K60E* 27.18 kcal/mol 24.41 kcal/mol
V113I* 27.44 kcal/mol 23.80 kcal/mol
*(ANG in which there is no conformational change of the catalytic residue His114).
doi:10.1371/journal.pone.0032479.t003
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the path traced by tertiary hydrogen bonds is an important
characteristic that may be used to infer how a perturbation caused
by a mutation exerts influence on a distant residue [44]. Similar
graph-theoretic studies have been carried out to understand
structure-function relationships of proteins and how amino acid
residues act as nucleation centers for protein folding [43,45]. We
have presented the hydrogen bond occupancies of amino acid
pairs occurring in the shortest paths for K17I, S28N, L35P and
K60E mutants in the order of increasing ribonucleolytic activity in
Table 1. Although, loss of ribonucleolytic activity has been
demonstrated in K17I [8], this is not the case for L35P. In a SNP
genotype distribution study carried out across six populations:
Japanese (n=167), Korean (n=90), Mongolian (n=92), Ovambos
(n=86), Turkish (n=87), and German (n=70), correlation
between clinical and genetic data for L35P, K60E and H76Q
could not be established because of limited allele frequency data
[21]. We compared the results obtained for K17I and L35P.
Considering the RMSD, RMSF, dihedral angle change and
hydrogen bond occupancies, we predict that L35P will exhibit loss
of angiogenic activity by the loss of ribonucleolytic activity.
The crystal structure study by Leonidas et al. [22] also
established that the obstruction of the pyrimidine-binding site by
Gln117, the existence of a hydrogen bond between Thr44-Thr80
and Asp116-Ser118, were structural weak points of ANG but not
found in other RNase A counterparts. We determined the
hydrogen bond occupancies for Thr44-Thr80 and Asp116-
Ser118 for all mutants (Table 2). The hydrogen bond occupancy
is highest for K17I variant (96.87% and 95.31%, respectively)
followed by L35P mutant (84.59% and 89.36%, respectively). The
occupancy values were lower in mutants retaining ribonucleolytic
activity. Site directed mutagenesis experiments carried out by
Harper and Vallee [46] showed that D116N, D116A and D116H
mutants had higher ribonucleolytic activity. The mutation
probably reorients the water structure associated with the side
chain of His114, creating a more favorable conformation for
Figure 13. Lowest-energy AutoDock poses of NCI-65828 with His114 in K17I and L35P mutants. Stereo views of lowest-energy AutoDock
poses of K17I and L35P mutants using NCI-65828. The backbone trace of ANG is shown along with the His114 residue as stick model depicting the
hydrogen bond between the azo-group of the inhibitor and His114 (in green dashed line). In K17I, (A) presence hydrogen bond in native
conformation with His114 (B) and its absence in the altered conformation of His114 were visualized. Similarly, in L35P, (C) presence hydrogen bond in
native conformation with His114 (D) and its absence in the altered conformation of His114 are shown. Also shown is how the conformational
switching of His114 affects substrate binding at the catalytic site.
doi:10.1371/journal.pone.0032479.g013
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L35P, confirms that the presence of H-bond through Asp116,
plays an important role in the loss of ribonucleolytic activity [46].
In addition, a study of the mutants of Thr44, reported in the
literature, T44A, T44H and T44D, had shown conclusively the
importance of Thr44 for angiogenic activity [47]. T44H, which is
2–4% active in cleaving polynucleotides, has at least 100 times less
angiogenic activity. In a subsequent study, it was established that
the Thr44-Thr80 hydrogen bond attenuates ribonucleolytic
activity of ANG [48]. Through their study of the T44A/T80A
and Q117A/T80A double mutants, they demonstrated that the
changes in potency and specificity were mediated by Thr44.
In addition to this, the hydrogen-bond interactions for each
docked conformation were examined. It was observed that the
hydrogen bond between the azo-group of NCI-65828 and His114
HD1 exists only for WT-ANG catalytic triad conformation. For
K17I and L35P, where there is a conformational switching of the
His114, the hydrogen bond ceases to exist when the dihedral angle
of His114 shifts by 99u (Figure 13). The binding energies
computed using AutoDock and ParDOCK both show consistent
Figure 14. Computed change in solvent accessible surface area for WT-ANG and mutants. Variation of solvent accessible surface area
(SASA) of nuclear localization signal residues R31, R32 and R33 over the period of simulation (A) WT-ANG (B) K17I (C) S28N (D) P112L (E) L35P (F) K60E
and (G) V113I. (R31: blue, R32: red and R33: green).
doi:10.1371/journal.pone.0032479.g014
Figure 15. Changes in folding of residues
31RRR
33 for WT-ANG, S28N and L35P mutants. Comparison of the changes in the folding of the
residues R31, R32 and R33 at initial condition and at 50 ns of simulation. The residues are in open conformation for WT-ANG throughout the duration
of simulation. For S28N and L35P mutants, a closed conformation is dominant. Figure produced using PyMOL [53].
doi:10.1371/journal.pone.0032479.g015
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(Table 3).
Loss of Nuclear Translocation Activity
Angiogenesis involves activation of endothelial cells and basement
membrane degradation, followed by translocation, proliferation, and
differentiation of the endothelial cells into capillary structures. In one
of the early investigations, it was demonstrated that nuclear
translocation of ANG was critical for angiogenesis. Moroianu and
Riordan [49,50] showed using immunoflorescence microscopy that
theR33Amutantwasnotinternalizedinproliferatingcalfpulmonary
artery endothelial (CPAE) cells. This established that the stretch of
three arginines,
31RRR
33, was part of the nuclear localization signal.
At the same time, two enzymatically inactive mutants, K40Q and
H13A, translocated to the nucleoli. Not all the mechanisms of actions
of ANG are well understood [51,52]. We have tried to understand
why certain mutants lost their nuclear translocation activity by
examining the changes in SASA. The SASAs for R31, R32 and R33,
were computed over the course of simulation for each mutant. It was
observed that S28N and P112L variants that had lost nuclear
translocation activity, possessed distinctly lower SASA compared to
K17I and K60E, which retained nuclear translocation activity
(Figure 14). As the simulation progressed, the R31, R32 and R33
residues, folded in a manner that was inaccessible to the solvent
(Figure 15). In V113I this happens within 2 ns of the simulation; for
S28N, P112L and L35P, this happens within 10 ns. The average
SASAoverthelast10 nsfor
31RRR
33 wascalculated for each mutant
from their respective MD trajectories. These values were summed
together and compared (Table 4). It was observed that for S28N and
P112L, for which the loss of nuclear translocation activity has been
confirmed experimentally [8], the total SASA was 8.26 A ˚ 2 and
11.46 A ˚ 2 respectively. For the V113I variant identified in Italian ALS
patients [16], the total SASAwas 3.86 A ˚ 2. Val113 is highly conserved
during evolution but located within the hydrophobic core of ANG.
Therefore, its role in angiogenesis is not clearly defined [16]. Our
results indicate that V113I is implicated in ALS probably by loss of
nuclear translocation activity. Since the lowest value of 3.66 A ˚ 2 was
obtained for L35P, our model indicates that this mutant may be
linked to ALS.
The other mutations K17I and K60E, which did not exhibit loss
of nuclear translocation activity, had a total SASA of 389.61 A ˚ 2
and 388.25 A ˚ 2, respectively over the last 10 ns duration and
compared well with the value of 391.16 A ˚ 2 for WT-ANG (see
Figure S8). The average volume calculated over 50 ns duration of
the smallest sphere that can enclose these three residues together is
also given in Table 4. The diameter was taken as the maximum
distance between the extremities of R31 and R33. The calculated
volume is distinctly lower for mutations exhibiting a loss of nuclear
translocation activity (see Figure S9).
The predictions of our model were also supported by the results
obtained from F-SNP database [39,40] (http://compbio.cs.
queensu.ca/F-SNP/) which classified T195C SNP encoding
L35P mutant as deleterious and A238G SNP encoding K60E as
benign. Our model indicates that L35P may exhibit a loss of
ribonucleolytic activity and nuclear translocation activity. How-
ever, in the absence of experimental studies, further genetic data
will be required to support our prediction about the role of L35P
mutant in ALS pathogenesis.
Supporting Information
Figure S1 Comparison of backbone RMSF values of
crystal structure and simulated structure. Comparison of
RMSF values of the backbone atoms calculated from the
crystallographic temperature factors (black line) and obtained from
MD simulation (red line) at 300 K, as a function of residue number.
(TIF)
Figure S2 Computed dihedral angle change of His114 of
WT-ANG in its mutant conformation. The HA-CA-CB-CG
dihedral angle change of catalytic residue His114 computed as a
function of time after rotating His114 about 99u similar to that of
the mutant conformation. His114 acquires its native conformation
within 1 ns time interval and stabilizes thereafter.
(TIF)
Figure S3 Conformational switching of catalytic residue
His114 in S28N and P112L variants. Reorientation of the
catalytic triad residue His114 at a regular interval of 10 ns over
50 ns time period during the MD simulation of S28N and P112L
variants. In these figures, T=0 ns is the time when the
temperature of the system has been maintained at 300 K. Figure
produced using PyMOL [53].
(TIF)
Figure S4 Conformational switching of catalytic residue
His114 in K60E and V113I mutants. Reorientation of the
catalytic triad residue His114 at a regular interval of 10 ns over
50 ns time period during the MD simulation of K60E and V113I
mutants. In these figures, T=0 ns is the time when the
temperature of the system has been maintained at 300 K. Figure
produced using PyMOL [53].
(TIF)
Figure S5 Residues interacting through hydrogen bonds
from the site of mutation to His114 in S28N variant.
Ribbon representation of S28N mutant angiogenin, residues
involved in the hydrogen bonding connected from the site of
mutation to catalytic residue His114 have been shown in stick
model and represented as marine blue color. Catalytic triad
residues have been shown as stick model and represented in green
color. Hydrogen bonds between residues are shown in red dotted
lines. Figure produced using PyMOL [53].
(TIF)
Figure S6 Lowest-energy AutoDock poses of NCI-65828
with His114 in WT-ANG. Stereoviews of lowest-energy
AutoDock poses of WT-ANG. The backbone trace of ANG is
shown along with the His114 residue as stick model. Predicted
hydrogen bond before conformational switching of His114 is
shown as dashed lines (green color).
(TIF)
Table 4. SASA values of R31, R32 and R33 over last 10 ns and
calculated smallest equivalent sphere volume for WT-ANG
and ANG mutants.
SASA (A ˚ 2) Volume (A ˚ 3)
ANG R31 R32 R33 Total
WT-ANG 187.72 122.09 81.35 391.16 2628.83
K17I 175.36 126.76 87.48 389.61 2502.31
S28N 3.19 2.65 2.42 8.26 783.04
P112L 4.79 3.93 2.74 11.46 717.44
L35P 1.13 1.27 1.24 3.66 784.39
K60E 175.69 128.06 84.50 388.25 2753.69
V113I 1.58 1.21 1.06 3.86 804.55
doi:10.1371/journal.pone.0032479.t004
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poses of NCI-65828 with His114 in K17I and L35P.
Binding orientation of NCI-65828 represented as stick model
predicted by the AutoDock Lamarckian Genetic Algorithm. ANG
and His114 are shown as surface model. (A) Predicted hydrogen
bond in native conformation of His114 is shown as dashed lines
(green color) and sphere in K17I. (B) No hydrogen bond formed in
altered conformation of His114 in K17I. (C) Predicted hydrogen
bond in native conformation of His114 is shown as dashed lines
(green color) and sphere in L35P mutant. (D) No hydrogen bond
formed in altered conformation of His114 in L35P mutant.
(TIF)
Figure S8 Average SASA values of nuclear localization
signal residues
31RRR
33 for WT-ANG and mutants. The
bar plot shows calculated average SASA of nuclear localization
signal residues
31RRR
33 over successive 10 ns time intervals for
WT-ANG and mutants. SASA values of all the ANG forms were
stable after 30 ns.
(TIF)
Figure S9 Computed volume of nuclear localization
signal residues
31RRR
33 for WT-ANG and mutants.
Calculated volume of the nuclear localization signal residues
31RRR
33 between WT-ANG and the mutants throughout the
course of simulations at 300 K. WT-ANG, K17I, S28N, P112L,
L35P, K60E, V113I are represented in black, red, dark green,
blue, orange, pink, and light green, respectively.
(TIF)
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